We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
LIDDS.ST

Price
0.03
Stock movement down
-0.01 (-15.50%)
Company name
Lidds AB
Exchange
(ST
,
Currency
SEK
)
Sector
Healthcare >
Biotechnology
Market cap
4.61M
Ent value
372.45K
Price/Sales
200.54
Price/Book
0.67
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
32.77%
1 year return
-80.12%
3 year return
-81.77%
5 year return
-70.32%
10 year return
-41.77%
Last updated: 2025-04-12

DIVIDENDS

LIDDS.ST does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales200.54
Price to Book0.67
EV to Sales16.19

FINANCIALS

Per share

Per share data
Current share count136.46M
EPS (TTM)-0.16
FCF per share (TTM)-0.06

Income statement

Income statement data
Revenue (TTM)23.00K
Gross profit (TTM)-687.00K
Operating income (TTM)-8.33M
Net income (TTM)-21.95M
EPS (TTM)-0.16
EPS (1y forward)-

Margins

Margins data
Gross margin (TTM)-2986.96%
Operating margin (TTM)-36221.74%
Profit margin (TTM)-95443.48%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash6.55M
Net receivables0.00
Total current assets7.73M
Goodwill0.00
Intangible assets1.21M
Property, plant and equipment0.00
Total assets9.21M
Accounts payable497.00K
Short/Current long term debt0.00
Total current liabilities1.38M
Total liabilities2.31M
Shareholder's equity6.89M
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-7.95M
Capital expenditures (TTM)115.00K
Free cash flow (TTM)-8.06M
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity-318.38%
Return on Assets-238.43%
Return on Invested Capital-318.38%
Cash Return on Invested Capital-116.97%

STOCK INFORMATION

Stock chart

Stock price data
Open0.04
Daily high0.04
Daily low0.03
Daily Volume169K
All-time high19.64
1y analyst estimate4.30
Beta0.18
EPS (TTM)-0.16
Dividend per share-
Ex-div date-
Next earnings date28 May 2025

Downside potential

Downside potential data
LIDDS.STS&P500
Current price drop from All-time high-99.83%-12.89%
Highest price drop-99.83%-56.47%
Date of highest drop11 Apr 20259 Mar 2009
Avg drop from high-44.77%-11.07%
Avg time to new high122 days12 days
Max time to new high1738 days1805 days
COMPANY DETAILS
LIDDS.ST (Lidds AB) company logo
Marketcap
4.61M
Marketcap category
Small-cap
Description
LIDDS AB (publ), a drug delivery company, develops pharmaceutical products based on its NanoZolid proprietary technology for the treatment of cancer and other diseases in Sweden. The company's oncology pipeline in clinical development includes Liproca Depot, a NanoZolid-formulated 2-hydroxyltutamide (2-HOF), which is an anti-androgen drug that binds and blocks androgen receptors; Nanodotax, a NanoZolid-formulated docetaxel, which is a chemotherapy medication that is approved for various oncological conditions, such as breast cancer, head and neck cancer, and prostate cancer; and Nanoimod, a NanoZolid-formulated agatolimod, which is a toll-like receptor 9 (TLR9) agonist. The company was founded in 2003 and is based in Uppsala, Sweden.
Employees
1
Website
https://www.liddspharma.com
Investor relations
-
SEC filings
LIDDS.ST SEC filings
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved